| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2172727 | Cytotherapy | 2011 | 9 Pages |
Abstract
GT therapy is a viable adjunctive treatment option for febrile neutropenia as a bridge to autologous hematopoietic recovery in patients with hematologic disease with tolerable toxicity. GT therapy requires close monitoring in patients with prior pneumonic infiltration and azotemia. It is recommended that transfusion with higher volumes is avoided.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Ki Hwan Kim, Hyo-Jeong Lim, Jin-Soo Kim, Byung-Su Kim, Soo-Mee Bang, Inho Kim, Kyu Sup Han, Byoung-Kook Kim, Sang-Min Lee, Sung-Soo Yoon,